Prof Andrew Chan speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the use of antithrombotic drugs to reduce the risk of gastrointestinal (GI) bleeding.

He discusses the current development of risk scores that aim to identify patients who are at high risk of GI bleeding.

Prof Chan emphasises that it is important to convey the preventative effects of aspirin versus the side effects to patients to help them make an informed decision.

He also believes there is good evidence to suggest the use of additional medications alongside aspirin to reduce the risk of bleeding, particularly in the high-risk population.

Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.